Ordinary Adjustment | Solactive Global Healthcare 20 Index | July 2018

In the ordinary rebalance the following composition will be implemented:

ABBVIE INC
ABBOTT LABORATORIES
AMGEN INC
ASTRAZENECA PLC
BAYER AG
BIOGEN INC
BRISTOL-MYERS SQUIBB CO
DANAHER CORP
GILEAD SCIENCES INC
GLAXOSMITHKLINE PLC
JOHNSON & JOHNSON
ELI LILLY & CO
MEDTRONIC PLC
MERCK & CO. INC.
NOVARTIS AG
NOVO NORDISK AS CLASS B
PFIZER INC
ROCHE HOLDING AG
SANOFI SA
THERMO FISHER SCIENTIFIC INC